Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Classificação em ações #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Preço da ação
$0.14942078
Última sincronização: 2025-05-15
Valor de mercado
$3.86M
Variação (1 dia)
0.10%
Variação (1 ano)
0.00%
País
DE
Negociar Medigene AG (MDG1)

Categoria

Lucros da Medigene AG (MDG1)
Lucros em Jun 2024 TTM: $-16.77M
De acordo com os últimos relatórios financeiros da Medigene AG, os ganhos atuais da empresa são de $-16.77M. Em 2022, a empresa teve ganhos de $-10.06M, um aumento em relação a aos ganhos de 2021, que foram de $-11.69M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Medigene AG de 2004 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-16.77M -8.57%
2023 $-18.34M 82.41%
2022 $-10.06M -14.01%
2021 $-11.69M -66.20%
2020 $-34.59M 54.79%
2019 $-22.35M -10.30%
2018 $-24.91M 60.47%
2017 $-15.53M 51.81%
2016 $-10.23M -33.71%
2015 $-15.43M 115.69%
2014 $-7.15M -49.32%
2013 $-14.11M -27.68%
2012 $-19.52M -2.57%
2011 $-20.03M -44.87%
2010 $-36.34M 15.53%
2009 $-31.45M -31.91%
2008 $-46.19M 0.82%
2007 $-45.82M 357.81%
2006 $-10.01M -29.67%
2005 $-14.23M -17.13%
2004 $-17.17M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$5.27B -31,555.72%
US
$1.95B -11,732.28%
NL
- -
CH
- -
KR
$3.01B -18,023.94%
BE